Search Results
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU
social-media commentary, softer-than-planned new-product launches, and weaker store traffic. On this news, lululemon's stock price fell $21.16 per share, or 17.38%, to close at $100.61 per share on September 4, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS
action]On August 20, 2026, OSI reported fiscal fourth-quarter and full-year 2026 financial results, including revenue that fell short of consensus expectations. OSI attributed the revenue miss to deferred product deliveries stemming from site constraints. On this news, OSI's stock
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
alanine transaminase (ALT) and/or aspartate aminotransferase (AST) elevations were also observed." On this news, Beam's stock price fell $2.83 per share, or 9.54%, to close at $26.83 per share on September 8, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("Lenz" or the "Company") (NASDAQ: LENZ). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
[Click here for information about joining the class action]On August 13, 2026, Abeona issued a press release "report[ing] financial results for the second quarter of 2026 and provid[ing] an update on commercial execution for ZEVASKYN (prademagene zamikeracel)." Abeona disclosed that
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION
sweat chloride when SION-719 was administered alongside the standard-of-care treatment Trikafta. On this news, Sionna's stock price fell $46.54 per share, or 91.18%, to close at $4.50 per share on August 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Klarna Group plc - KLAR
[Click here for information about joining the class action]On or around September 10, 2025, Klarna completed its initial public offering ("IPO"), selling 34.3 million shares priced at $40.00. Then, on August 18, 2026, Klarna announced its financial results for the second quarter of
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
joining the class action]On August 10, 2026, AirSculpt announced its financial results for the second quarter of fiscal 2026. The Company reported revenue of $42.9 million, down from $44.0 million in the same period in the prior year. On this news, AirSculpt's stock price fell
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qfin Holdings, Inc. - QFIN
funding costs and systemic liquidity shocks in the Chinese consumer credit market. On this news, Qfin's American Depositary Receipt ("ADR") price fell $2.18 per ADR, or 18.91%, to close at $9.35 per ADR on August 26, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. - SEDG
action]On August 5, 2026, SolarEdge reported its financial results for the second quarter of 2026. Among other items, SolarEdge forecasted Q3 2026 revenue in the range of $310 million to $340 million, well below the consensus analyst estimates of around $371 million. On this news, SolarEdge's
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of D-Wave Quantum Inc. - QBTS
and missing analyst expectations in the range of $4.03 million to $4.08 million. On this news, D-Wave's stock price fell $1.99 per share, or 9.28%, to close at $19.41 per share on August 6, 2026. Then, on August 25, 2026, D-Wave issued a press release "announc[ing] that John Markovich is retiring
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JinkoSolar Holding Co., Ltd. - JKS
2025, discussing the Company's third quarter financial results. On this news, JinkoSolar's American Depositary Receipt ("ADR") price fell $2.88 per ADR, or 11.89%, to close at $21.34 per ADR on April 16, 2026. Then, on August 26, 2026, JinkoSolar reported its financial results for the second
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS
clinical trial. However, as of the time of that report, Sellas had yet to release the trial results. On this news, Sellas's stock price fell $2.00 per share, or 13.15%, to close at $13.21 per share on August 28, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of L3Harris Technologies, Inc. - LHX
Kubasik that was not consistent with the values of the Company as outlined in its Code of Conduct.On this news, L3Harris's stock price fell $13.44 per share, or 4.61%, to close at $278.38 per share on August 17, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:32 ET Ventura Music Festival's Fall Series Brings Diverse Live Music to Iconic Ventura Venues, Oct. 11-18
brings A Tribute to Quincy Jones on Oct 18 at Rancho Campana PAC; Grammy-nominated conductor Chris Walden leads, featuring vocalists Nayanna Holley, Adam "Aejaye" JacksonBluegrass Fiddle Legends Michael Cleveland and Jason Carter perform at Mission Park on October 17Season closes December
More news about: Ventura Music Festival
Sep 24, 2026, 17:31 ET Kinross Gold Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Kinross Gold (KGC)
24, 2026 /PRNewswire/ -- Kinross Gold Corporation (NYSE: KGC) fell sharply when the market opened on September 24, 2026, and by midday had fallen to a more than 10% decline. If you lost money on Kinross Gold, you are encouraged to
More news about: SueWallSt.com
Sep 24, 2026, 17:30 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Dun & Bradstreet Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - DNB
Schedule 14A on May 13, 2025 (the "Proxy"). Dun & Bradstreet stockholders voted to approve the merger on June 12, 2025, and the merger closed on August 26, 2025.A complaint has been filed alleging that defendants made false and/or misleading statements and/or failed to disclose material facts
More news about: Pomerantz LLP
Sep 24, 2026, 17:30 ET Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
GrowthThe increasing prevalence of multiple sclerosis, growing awareness of neurological disorders, improved diagnostic capabilities, and rising emphasis on early disease management are driving demand for effective MS treatments. Growing adoption of disease-modifying therapies (DMTs), including immunomodulators,
More news about: Maximize Market Research Pvt. Ltd.
Sep 24, 2026, 17:28 ET NAIC Letter Details Proactive State Oversight of Evolving Insurance Landscape
"Rather than relying on a static regulatory framework, regulators have regularly updated capital requirements, reporting standards, supervisory tools, and analytical capabilities to address emerging risks while maintaining a consistent focus on insurer solvency and policyholder protection,"
More news about: NATIONAL ASSOCIATION OF INSURANCE COMMISSIONERS
Sep 24, 2026, 17:26 ET webAI Lands $30 Million AI Deal With Forge as Enterprise AI Services Race Accelerates
and services operation. Forge will work directly with customers to build AI systems around their proprietary data, workflows and operations, running on infrastructure those customers control.The agreement comes as the AI market begins shifting from building increasingly capable general-purpose
More news about: webAI
Sep 24, 2026, 17:25 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ryde Group Ltd. of Class Action Lawsuit and Upcoming Deadlines - RYDE
[Click here for information about joining the class action]A Complaint has been filed on behalf of investors in Ryde securities, arising out of the sudden collapse of Ryde's stock in September 2024, following a run-up allegedly
More news about: Pomerantz LLP
Sep 24, 2026, 17:23 ET True Sea Moss Launches Sparkling Hydration, a New Line of Electrolyte Drinks Made With Sea Moss and Real Fruit
line reflects True Sea Moss's continued focus on clean, food-first formulas: real ingredients, no artificial sweeteners, and a functional mineral profile consumers can understand at a glance.The launch will expand to retail stores across the nation and on
More news about: True Sea Moss
Sep 24, 2026, 17:22 ET BobaVida Kicks the Door Open on the Drink Aisle With ORBA, a Ready-to-Drink Popping Boba Beverage Shipping November 1
and monk fruit; no artificial sweeteners, no sugar alcohols, no corn syrup45 calories and 5g prebiotic fiber per pouch on the tea base; 70 calories and 5g fiber on the coconut water basePlant-based color; shelf-stable with a 14-month shelf life; best served chilledFour-packs
More news about: BobaVida
Sep 24, 2026, 17:20 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBNX
back-file some additional customer complaints that were very minor in nature and required no medical intervention.Then, on January 8, 2026, Beta Bionics reported an unexpected miss on new iLet patient starts. The announcement revealed that facts reported previously by the Capitol Forum in December – that
More news about: Pomerantz LLP
Sep 24, 2026, 17:15 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in DICK'S Sporting Goods, Inc. of Class Action Lawsuit and Upcoming Deadlines - DKS
about joining the class action]On September 8, 2025, Dick's announced the completion of its acquisition of Foot Locker, Inc. ("Foot Locker"), a prominent footwear and apparel retailer, for approximately $2.5 billion in cash and stock.On August 25, 2026, before the market opened, Dick's
More news about: Pomerantz LLP